Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- nuravax.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Evaluate the safety, tolerability, and immunogenicity of adjuvanted preventive dual AΒ/TAU vaccine, duvax in healthy… | National Institute on Aging (NIH) | $1,757,036 |
Quick answers
Is Nuravax, Inc. registered in SAM.gov?
Yes. Nuravax, Inc.'s SAM.gov registration is active through September 16, 2027.
What is Nuravax, Inc.'s most recent federal award?
Nuravax, Inc.'s most recent federal grant award is Evaluate the safety, tolerability, and immunogenicity of adjuvanted preventive dual AΒ/TAU vaccine, duvax in healthy… (R44AG091903), from National Institute on Aging (NIH), on March 25, 2025.
On GovTribe
See Nuravax, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors